LAWRENCE, Mass., July 24 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced the addition of Jonathan Silverstein, General Partner of OrbiMed Advisors, LLC, ("OrbiMed"), to its Board of Directors. NxStage elected a representative from OrbiMed to its Board in connection with the recently announced private placement. The appointment of Mr. Silverstein fills a current vacancy on the Board and brings the number of members on NxStage's Board to eight. "NxStage is pioneering a market with disruptive and innovative technology that is designed to dramatically improve the quality of life for patients with ESRD (end-stage renal disease)," stated Jonathan Silverstein. "I'm excited to join the team and to help NxStage achieve its strategic initiatives." "Jonathan...
[read full story]